RYTM earnings: real EPS beat/miss history, analyst consensus Buy, P/E -33.22. Updated 2026-07-23.
Rhythm Pharmaceuticals (RYTM) Research Hub
Rhythm Pharmaceuticals (RYTM) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 104.71 USD (+3.61%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -33.22, market cap 7.08B. This hub links to the full technical, earnings and options research available for RYTM.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 104.71 USD (+3.61%) |
| 52-week range | 89.03 USD – 119.75 USD |
| Trend regime | Range |
| 14-day RSI | 33 (Bearish) |
| Trailing P/E | -33.22 |
| Market cap | 7.08B |
| Dividend yield | 0.00% |
Available research for RYTM
Covered Call on RYTM: how it works, illustrative setup around the real 104.71 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on RYTM: how it works, illustrative setup around the real 104.71 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on RYTM: how it works, illustrative setup around the real 104.71 USD price, max profit/loss, breakeven and when to use it. Educational.
RYTM technical analysis: range, last 104.71 USD, RSI 33, 52w range 89.03 USD–119.75 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is RYTM in?
Rhythm Pharmaceuticals (RYTM) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is RYTM in an uptrend or downtrend?
As of 2026-09-11, RYTM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is RYTM's trailing P/E ratio?
RYTM's trailing P/E is -33.22, with a market cap of 7.08B. See the earnings research page for full valuation detail.